About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The 340B program has evolved dramatically from its original purpose — and patients are paying the price. Instead of lowering costs for patients, the program serves as a virtually oversight-free revenue stream for large, tax-exempt hospitals, clinics and their for-profit partners. New data shows just how lucrative the program has become: hospitals, clinics and their for-profit partners pocketed an estimated $142 billion in profits from the 340B program in 2025.